Novel oral Anticoagulants in Non-Valvular Atrial Fibrillation
Atrial fibrillation is the most frequent arrhythmia in clinical practice, reaching 2% of the people in the world and is associated with systemic embolism. Thus, the use of anticoagulants is indicated if CHA2DS2-VASc score ≥2 or in patients with previous transient ischemic attack or stroke. For decad...
| Main Author: | |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Bentham Science Publishers
2014
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4428103/ |